Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease

Catheterization and Cardiovascular Diagnosis

Volumn 45, Issue 3, 1998, Pages 264-268

  Etheridge, Susan P ^a   Tani, Lloyd Y ^a   Luann Minich, L ^a   Revenaugh, James R ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Utah Heart Clinic   (United States)

Author keywords

Abciximab; Angiography; Coronary artery disease; Echocardiography

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; WARFARIN;

ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CORONARY ARTERY ANEURYSM; CORONARY ARTERY THROMBOSIS; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INFANT; LABORATORY TEST; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHYSICAL EXAMINATION; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ASPIRIN; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 0031786918     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199811)45:3<264::AID-CCD10>3.0.CO;2-2     Document Type: Article

References (15)

1. Tuabert KA, Rowley AH, Shulman ST: A nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119:279-282, 1991.
2. Centers for Disease Control: Kawasaki disease - New York. MMWR 29:61-63, 1980.
3. EPILOG Investigators: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336:1689-1696, 1997.
4. Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DYM, Wilson H, Glode MP: Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759-763, 1986.
5. Fujiwara H, Hamashima Y: Pathology of the heart in Kawasaki disease. Pediatrics 61:100-107, 1978.
6. Fujiwara T, Fujiwara H, Nakano H: Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Circulation 78:345-350, 1988.
7. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hisks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME: The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347, 1986.
8. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinamiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Mori C: High-dose intravenous gamma globulin for Kawasaki disease. Lancet 2:1055-1058, 1984.
9. Inagaki M, Yamada K: Inhibitory effects of high-dose intravenous gamma globulin on platelet interaction with vessel wall in Kawasaki disease. Acta Paediatr Jpn 33:791-798, 1991.
10. Kato H. Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R: Long-term consequences of Kawasaki disease: A 10-21-year follow-up study of 594 patients. Circulation 94:1379-1385, 1996.
11. Kato H, Inoue O, Ichinose E, Akagi T, Sato N: Intracoronary urokinase in Kawasaki disease: Treatment and prevention of myocardial infarction. Acta Paediatr Jpn 33:27-35, 1991.
12. Suzuki A, Tetsuro K, Ono Y, Kinoshita Y: Thrombolysis in the treatment of patients with Kawasaki disease. Cardiol Young 3:207-215, 1993.
13. Tsubata S, Ichida, F, Hamamichi Y, Miyazaki A, Hashimoto I, Okada T: Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease. Pediatr Cardiol 16:186-189, 1995.
14. Phillips DR, Chara IF, Parise LV, Fitzgerald LA: The platelet membrane glycoprotein IIb/IIIa complex. Blood 71:831-843, 1988.
15. EPIC Investigators: Use of a monoclonal antibody directed against platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956-961, 1994.